James M. Pullman
Advanced microscopy technology including computational microscopy
<p>Clinical areas of expertise include heart failure, cardiac transplantation, mechanical circulatory support.</p>
<p>The treatment of all arrhythmias with a special interest in catheter ablation and cardiac resynchronization therapy.</p>
<p>Dr. Palma's past research has focused on the outcomes of catheter ablation and pioneering interventional electrophysiology techniques.</p>
<FONT face=Arial color=#000000> </FONT>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>BOOK CHAPTERS<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>1)<B style="mso-bidi-font-weight: normal"> Palma E </B>and Scheinman, M. 2000. “Treatment of Cardiac Arrhythmias with Catheter-Ablative Techniques.”<SPAN style="mso-spacerun: yes"> </SPAN>In: Alexander RW, Schlant RC, Fuster V, eds<B style="mso-bidi-font-weight: normal">.<SPAN style="mso-spacerun: yes"> </SPAN><I style="mso-bidi-font-style: normal">The Heart (10<SUP>th</SUP> and 11<SUP>th</SUP> editions</I></B><I style="mso-bidi-font-style: normal">)</I>.<SPAN style="mso-spacerun: yes"> </SPAN>New York, NY.<SPAN style="mso-spacerun: yes"> </SPAN>McGraw-Hill.<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>ARTICLES<o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT color=#000000><FONT face=Arial>1)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line">Fisher JD, Kim SG, Ferrick KJ, Gross JN, <B style="mso-bidi-font-weight: normal">Palma EC</B>, Scavin GM.<SPAN style="mso-spacerun: yes"> </SPAN></SPAN></FONT></FONT></FONT></P>
<P class=MsoBodyText2 style="MARGIN-LEFT: 0.25in"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">Simplified Tilt table test protocol with continuous upright position during medication administration and no hydration. </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> <SPAN style="LAYOUT-GRID-MODE: line">2003; 26:451-452<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>2)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Green J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>What is the Mechanism of the Tachycardia?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Cardiov Electrophys</I></B> 2003. 14(4):435-436</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>3)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Vaidya K, Kim S, Gross J, Ferrick K, <B style="mso-bidi-font-weight: normal">Palma E, </B>Furman S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Runaway pulse generator malfunction resulting from undetected battery depletion.<SPAN style="FONT-FAMILY: Tahoma; mso-bidi-font-family: 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B><SPAN style="mso-spacerun: yes"> </SPAN>2002; 25(2):220-222</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>4)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Saxenberg V, Vijayraman P, Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Histopathologic Correlation of Ablation Lesions Guided by Noncontact Mapping in a Patient with Peripartum Cardiomyopathy and Ventricular Tachycardia.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 2001; 24:1812-1815</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>5)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Vijayraman P, Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Sinus node recovery after 25 years of atrial flutter.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B><SPAN style="mso-spacerun: yes"> </SPAN>2001, 24(8): 1295-1296</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>6)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma, E.<SPAN style="mso-spacerun: yes"> </SPAN></B>Therapeutic options in patients with non-sustained ventricular tachycardia and reduced left ventricular ejection fraction.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Current Cardiology Reports</B> 2001 3(3): 219-223. Ed-in-Chief: Valentin Fuster;<SPAN style="mso-spacerun: yes"> </SPAN>Section Editor:<SPAN style="mso-spacerun: yes"> </SPAN>Thierry LeJemtel</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l17 level1 lfo21"><FONT face=Arial color=#000000>7)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Vijayraman P, Ferrick K, Gross J, Kim S and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Is this SVT or VT?<SPAN style="mso-spacerun: yes"> </SPAN>An Exception to the rule.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Journal of Interventional Cardiac Electrophysiology</B><SPAN style="mso-spacerun: yes"> </SPAN>2001 March, 5(1):67-70</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><B style="mso-bidi-font-weight: normal"><FONT color=#000000><FONT face=Arial> </FONT></FONT></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><FONT color=#000000><FONT face=Arial>8)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Ferrick K, Gross J, Kim S, and Fisher J.<SPAN style="mso-spacerun: yes"> </SPAN>Transition from AV Node Reentry Tachycardia to Atrial Fibrillation Begins in the Pulmonary Veins.<SPAN style="mso-spacerun: yes"> </SPAN></FONT></FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal">Circulation </B>2000<B style="mso-bidi-font-weight: normal"> </B>Aug 22, 102(8): 937</FONT></FONT></P>
<P class=MsoBodyText style="mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>9)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Cui, J, Melman, Y, <B style="mso-bidi-font-weight: normal">Palma E, </B>Fishman G and McDonald T<B style="mso-bidi-font-weight: normal">.<SPAN style="mso-spacerun: yes"> </SPAN></B>Cyclic AMP modulates<SPAN style="mso-spacerun: yes"> </SPAN>the HERG K+ Channel by Dual Pathways.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Curr Biol.</I></B> 2000 Jun 1;10(11):671-674</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>10)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E, </B>Gross J.<SPAN style="mso-spacerun: yes"> </SPAN>Understanding the mode switching algorithm of the Intermedics Marathon (Invited Review).<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Herzschrittmachertherapie & Elektrophysiologie </I></B>1999 June, 10 (Suppl 2): I/67-71</FONT></FONT></P>
<P class=MsoNormal><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><FONT face=Arial color=#000000>11)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Antonelli D, Rosenfeld T, Freedberg N, <B style="mso-bidi-font-weight: normal">Palma E</B>, Gross J, Furman S. Insulation lead failure: is it a matter of insulation coating, venous approach, or both? </FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 1998 Feb, 21(2): 418-21</FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>12)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>McDonald TV, Yu Z, Ming Z, <B style="mso-bidi-font-weight: normal">Palma E</B>, Meyers M, Wang K, Goldstein SAN,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman GI. A minK-HERG complex regulates the cardiac potassium current <I style="mso-bidi-font-style: normal">I</I><SUB>Kr</SUB>. <B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Nature</I></B> 1997, 388: 289-292 </FONT></FONT><FONT face=Arial color=#000000>13)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The effect of varying atrial sensitivity, AV interval, and detection algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>automatic mode switching. </FONT></FONT><FONT color=#000000><FONT face=Arial><SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 1996, 19(Pt. II): 1734-1739</FONT></FONT></P>
<P class=MsoNormal style="tab-stops: 2.0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="tab-stops: 2.0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-ALIGN: center; tab-stops: 2.0in" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>ABSTRACTS<o:p></o:p></FONT></SPAN></B></P>
<P class=MsoBodyText style="TEXT-INDENT: -4.5pt; tab-stops: .25in; mso-list: none"><FONT color=#000000><FONT face=Arial><SPAN style="mso-tab-count: 3"> </SPAN><SPAN style="mso-tab-count: 2"> </SPAN><SPAN style="mso-tab-count: 2"> </SPAN><SPAN style="mso-tab-count: 1"> </SPAN></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">1)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Vijayaraman P, <B>Palma E</B>, Shepard R, Wood M, and Ellenbogen K.<SPAN style="mso-spacerun: yes"> </SPAN>Intra-atrial conduction block at the mitral and tricuspid annulus along the coronary sinus during radiofrequency catheter ablation.<SPAN style="mso-spacerun: yes"> </SPAN><B><I>Heart Rhythm Journal</I></B> 1 (1S): S230, 2004; Poster Presentation at the Heart Rhythm Society Meetings, San Francisco, CA<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">2)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Kim S, Del Vecchio A, Ferrick K, Fisher J, Gross J, and <B>Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Facilitation of axillary and cephalic vein cannulation by radio-opaque guide wire inserted via antecubital veins before device implantation.<SPAN style="mso-spacerun: yes"> </SPAN><B><I>Heart Rhythm Journal</I></B> 1 (1S): S176, 2004; Oral Presentation at the Heart Rhythm Society Meetings, San Francisco, CA<o:p></o:p></SPAN></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial><SPAN style="LAYOUT-GRID-MODE: line">3)<SPAN style="FONT: 7pt 'Times New Roman'"><FONT size=3> </FONT></SPAN></SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Green J, Bhatt K, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> Mortality of Patients on Dialysis at the time of ICD Implantation.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2003; Oral Presentation at the 3rd International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 12-15, 2003</SPAN></FONT></FONT><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></SPAN></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial>4)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Patel A, Chen T, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> Should Clopidogrel Be Discontinued Before Implanting a device?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2003; Oral Presentation at the 3rd International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 12-15, 2003</SPAN></FONT></FONT></FONT></P>
<P class=MsoBodyText style="MARGIN-LEFT: 0in; TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>5)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Kim S, Gross J, Ferrick K, Fisher J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Non-contact<SPAN style="mso-spacerun: yes"> </SPAN>Mapping of Right Atrial Activation During Pulmonary Vein Pacing.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Am Coll Cardiol</I></B> 2001. 39 (5 suppl A): 115A. </FONT></FONT><FONT face=Arial color=#000000>Poster Presentation at the American College of Cardiology 49th Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Atlanta, GA, March 17-20, 2001</FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT color=#000000><FONT face=Arial>6)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><SPAN style="LAYOUT-GRID-MODE: line; COLOR: black">Banchs J, Weiner S, Vijayaraman P, Ferrick K, Fisher J, Kim S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>.</SPAN> ICD Mortality In Octagenarians.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Journal of Heart Disease</I></B> 2001; 2(1): 114; Poster Presentation at the 2<SUP>nd</SUP> International Heart Disease Congress.<SPAN style="LAYOUT-GRID-MODE: line; COLOR: black"><SPAN style="mso-spacerun: yes"> </SPAN>Washington, DC, July 21-24, 2001</SPAN></FONT></FONT></FONT><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>7)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weiner S, Vijayaraman P, Ferrick K, Kim S, Fisher S, Furman S, Gross J, and <B style="mso-bidi-font-weight: normal">Palma E</B>. Is Post-Operative Atrial Fibrillation a Left Atrial Disease?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>2001 24(4 II): 676; Poster Presentation at the NASPE 22nd Annual Scientific Sessions. Boston, MA, May 2-5, 2001</FONT></FONT><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>8)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, Goseki Y, Sparks P, Kinugawa K, Roithinger F, Nakai T, <B style="mso-bidi-font-weight: normal">Palma E</B>, Lesh M, Keung E, Simpson P, and Lee R. Rapid Atrial Pacing Causes Atrial Remodeling and Genetic Reprogramming in a Canine Model of Chronic Atrial Fibrillation.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I></B> 2000; 23 (4 Part II): 639. </FONT></FONT><FONT face=Arial color=#000000>Poster Presentation at the NASPE 21st Annual Scientific Sessions. </FONT><FONT face=Arial color=#000000>Washington, DC, May 17-20, 2000</FONT></P>
<P class=MsoBodyText style="TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>9)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, <B style="mso-bidi-font-weight: normal">Palma E</B>, Roithinger F, Kinugawa K, Goseki Y, Sparks P, Lesh M, Keung E, Simpson P, and Lee R.<SPAN style="mso-spacerun: yes"> </SPAN>The Role of Genetic Reprogramming in a Canine Model of Chronic Atrial Fibrillation – Alterations in Gene Expression of Markers of Hypertrophy and Calcium Homeostasis Proteins. </FONT></FONT><FONT color=#000000><FONT face=Arial><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">J Am Coll Cardiol</I></B> 2000. 35 (2 suppl A): 146A</FONT></FONT><FONT face=Arial color=#000000>Oral Presentation at the American College of Cardiology 49th Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Anaheim, CA, March 12-15, 2000</FONT></P>
<P class=MsoBodyText style="TEXT-INDENT: 0in; mso-list: none"><FONT color=#000000><FONT face=Arial> </FONT></FONT><FONT face=Arial color=#000000>10)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Weyerbrock S, <B style="mso-bidi-font-weight: normal">Palma E</B>, Roithinger F, Gozeki Y, Lesh M, Keung E, Simpson P, Lee R.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Fibrillation in a Chronic Dog Model Alters the Protein Level of the Na/Ca Exchanger and SERCA.</FONT></FONT><FONT color=#000000><FONT face=Arial><FONT size=3><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="mso-tab-count: 1"> </SPAN>Pacing and Clinical Electrophysiology</I></B> 1999; 22 (4 Part II): 726</FONT></FONT></FONT><FONT color=#000000><FONT face=Arial><SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the NASPE 20<SUP>th</SUP> Annual Scientific Sessions. Toronto, Canada May 12-15, 1999</FONT></FONT></P>
<P class=MsoBodyText style="mso-list: none"><FONT color=#000000><FONT face=Arial> <o:p></o:p></FONT></FONT></P>
<P class=MsoBodyText style="tab-stops: list .25in; mso-list: l2 level1 lfo30"><FONT face=Arial color=#000000>11)<FONT size=3><SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Ming Z, Yu Z,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman G, McDonald TV.<SPAN style="mso-spacerun: yes"> </SPAN>Cyclic-AMP-Dependent Phosphorylation and Regulation of HERG.</FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1998 October 27, 98 (17 Supplement): I-57</SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><SPAN style="mso-tab-count: 1"> </SPAN>Oral Presentation at the American Heart Association 1998 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Dallas, TX, November 8-11, 1998</FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in"><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">12)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Ma T, Keung EC, Gallinghouse GJ, Weyerbrock SW, Long CS, Simpson PC, Lee RJ. Adenoviral Overexpression of SERCA2a Prevents Triggered Activity induced by lnterleukin-1</SPAN><FONT face=Arial><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Symbol; mso-bidi-font-size: 10.0pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">b</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> in Neonatal Rat Myocytes. </SPAN></FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1998 October 27, 98 (17 Supplement): I-415</SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><SPAN style="mso-tab-count: 1"> </SPAN>Poster Presentation at the American Heart Association 1998 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Dallas, TX, November 8-11, 1998<B style="mso-bidi-font-weight: normal"><o:p></o:p></B></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>13)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Keung EC, Simpson PC, Long CS, Lee RJ. Cytokine-Induced Triggered Activity: A New Mechanism of Arrhythmogenesis. </FONT></SPAN><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Pacing and Clinical Electrophysiology</SPAN></I></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1998; 21, 4 (Pt II): 898. </SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>Poster Presentation at the NASPE 19<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>San Diego, CA, May 6-9, 1998<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="tab-stops: 0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 0in .25in"><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">14)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Gallinghouse GJ, Ma T, Keung EC, SImpson PC, Long CS, Lee RJ.<SPAN style="mso-spacerun: yes"> </SPAN>The Effect of Adenoviral Overexpression of SERCA2a on IL-1</SPAN><FONT face=Arial><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Symbol; mso-bidi-font-size: 10.0pt; mso-ascii-font-family: Arial; mso-hansi-font-family: Arial; mso-char-type: symbol; mso-symbol-font-family: Symbol"><SPAN style="mso-char-type: symbol; mso-symbol-font-family: Symbol">b</SPAN></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> Action Potential Prolongation in Neonatal Rat Myocytes. </SPAN></FONT></FONT><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Pacing and Clinical Electrophysiology</SPAN></I></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1998; 21, 4 (Pt II): 857. </SPAN></FONT><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>Featured Poster at the NASPE 19<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>San Diego, CA, May 6-9, 1998<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-INDENT: 0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>15) McDonald T, Ming Z, <B style="mso-bidi-font-weight: normal">Palma E, </B>Yu Z,<SPAN style="mso-spacerun: yes"> </SPAN>Fishman G.<SPAN style="mso-spacerun: yes"> </SPAN>MinK Enhances Functional Expression of HERG-K+ Currents in CHO Cell Co-Transfection Studies. </FONT></SPAN><FONT color=#000000><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Circulation</SPAN></I></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"> 1996; 94, 8: I –163.<SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the American Heart Association 1997 Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>New Orleans, LA, November 10-13, 1996<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="tab-stops: 0in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>16) <B style="mso-bidi-font-weight: normal">Palma E</B>, Andrews C, Hanson S, Cua M, Gross J, Furman S.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Arrhythmias and Survival of the VDD Mode in Single-Lead VDD Pacemakers.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>1996; 19, 4 (II): 636.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation in NASPE 17<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Seattle, WA, May 15-18, 1996<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>17) <B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The Effect of Varying Atrial Sensitivity, AV interval, and Detection Algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>Automatic Mode Switching.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Pacing and Clinical Electrophysiology</I> </B>1996; 19, 4 (II): 636.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation in NASPE 17<SUP>th</SUP> Annual Scientific Sessions.<SPAN style="mso-spacerun: yes"> </SPAN>Seattle, WA, May 15-18, 1996<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN></B><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<P class=MsoNormal style="TEXT-ALIGN: center" align=center><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">INTERNATIONAL ABSTRACTS AND PRESENTATIONS</SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><o:p></o:p></SPAN></FONT></P>
<H2 style="MARGIN-RIGHT: 4.3pt; TEXT-ALIGN: left; tab-stops: 369.0pt" align=left><SPAN style="mso-tab-count: 1"><FONT face=Arial color=#000000 size=3></FONT></SPAN></H2>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in 189.0pt"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>1)<SPAN style="mso-spacerun: yes"> </SPAN>I Stathopoulos, SG Kim, JN Gross, KJ Ferrick, JD Fisher, EC Palma.<SPAN style="mso-spacerun: yes"> </SPAN>Should Antiarrhythmics be stopped after atrial flutter ablation if afib is present?<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">European Journal of Cardiac Pacing and Electrophysiology </B>2004 </FONT></SPAN><FONT color=#000000><FONT face=Arial><FONT size=3><SPAN style="mso-spacerun: yes"> </SPAN>Poster presentation at the Cardiostim 2004 14<SUP>th</SUP> International Congress. </FONT></FONT></FONT><FONT face=Arial color=#000000 size=3>Nice, France June 19-22, 2004</FONT></P>
<P class=MsoNormal style="tab-stops: 2.0in 189.0pt"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> </FONT></SPAN><FONT color=#000000><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">2)<SPAN style="mso-spacerun: yes"> </SPAN>A. Lee, SG Kim, JN Gross, KJ Ferrick, JD Fisher, EC Palma</SPAN><FONT face=Arial>. <SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">Non-Contact Mapping of Right Atrial Activation During Non-isthmus-dependent Atrial Flutter. <B style="mso-bidi-font-weight: normal">European Journal of Cardiac Pacing and Electrophysiology </B>2002. </SPAN></FONT></FONT><FONT color=#000000><FONT face=Arial><FONT size=3><SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 2002 13<SUP>th</SUP> International Congress. </FONT></FONT></FONT><FONT face=Arial color=#000000 size=3>Nice, France June 19-22, 2002</FONT><FONT color=#000000><FONT face=Arial><FONT size=3> <o:p></o:p></FONT></FONT></FONT></P>
<H2 style="MARGIN: 0in 4.3pt 0pt 0.25in; TEXT-INDENT: -0.25in; TEXT-ALIGN: left; tab-stops: list .25in left 369.0pt; mso-list: l26 level1 lfo25" align=left><FONT face=Arial color=#000000 size=3>2)<SPAN style="FONT: 7pt 'Times New Roman'"> </SPAN>Vijayraman P, Kim S, Gross J, Ferrick K, Fisher J and <B style="mso-bidi-font-weight: normal">Palma E</B>.<SPAN style="mso-spacerun: yes"> </SPAN>Non-contact Mapping of Right Atrial Activation During Pulmonary Vein Pacing.<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal"><I style="mso-bidi-font-style: normal">Europace</I></B> 2001; 2(suppl C): C13;<SPAN style="mso-spacerun: yes"> </SPAN>Oral Presentation at the 7<SUP>th</SUP> International Workshop on Cardiac Arrhythmias, Venice , Italy<SPAN style="mso-spacerun: yes"> </SPAN>October 7-10, 2001</FONT></H2>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: .25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>3)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Andrews C, Hanson S, Cua M, Gross J, Furman S.<SPAN style="mso-spacerun: yes"> </SPAN>Atrial Arrhythmias and Survival of the VDD Mode in Single-Lead VDD Pacemakers.<o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in; tab-stops: 2.0in 189.0pt"><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>European Journal of Cardiac Pacing and Electrophysiology </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1996; 6, 1 (Suppl 5):242.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 1996 10<SUP>th</SUP> International Congress.<SPAN style="mso-spacerun: yes"> </SPAN>June 19-22, 1996, Nice, France <B style="mso-bidi-font-weight: normal"><o:p></o:p></B></SPAN></FONT></P>
<P class=MsoNormal><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -0.25in"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000>4)<SPAN style="mso-spacerun: yes"> </SPAN><B style="mso-bidi-font-weight: normal">Palma E</B>, Kedarnath V, Vankawalla V, Hanson S, Andrews C, Furman S, Gross J. The Effect of Varying Atrial Sensitivity, AV interval, and Detection Algorithm on<SPAN style="mso-spacerun: yes"> </SPAN>Automatic Mode Switching.<SPAN style="mso-spacerun: yes"> </SPAN><o:p></o:p></FONT></SPAN></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -13.5pt; tab-stops: .25in 2.0in 189.0pt"><FONT color=#000000><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><SPAN style="mso-tab-count: 1"> </SPAN>European Journal of Cardiac Pacing and Electrophysiology </SPAN></B><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'">1996; 6, 1 (Suppl 5): 197.<SPAN style="mso-spacerun: yes"> </SPAN>Oral presentation at the Cardiostim 1996 10<SUP>th</SUP> International Congress.<SPAN style="mso-spacerun: yes"> </SPAN>June 19-22, 1996, Nice, France<o:p></o:p></SPAN></FONT></P>
<P class=MsoNormal style="MARGIN-LEFT: 0.25in; TEXT-INDENT: -13.5pt; tab-stops: .25in 2.0in 189.0pt"><B style="mso-bidi-font-weight: normal"><SPAN style="FONT-SIZE: 12pt; FONT-FAMILY: Arial; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: 'Times New Roman'"><FONT color=#000000> <o:p></o:p></FONT></SPAN></B></P>
<p>Eugen C. Palma, MD, FACC, FHRS, is a Professor of Medicine and the Director of Weiler Arrhythmia Service at Montefiore and our <a href="http://www.einstein.yu.edu/faculty/5316/eugen-palma/" rel="noopener noreferrer" target="_blank">Albert Einstein College of Medicine</a>. His clinical focus is on the treatment of all arrhythmias, with a special interest in catheter ablation and cardiac resynchronization therapy. Dr. Palma joined the Montefiore team in 1999.</p><p>Dr. Palma received his Bachelor of Science in Basic Medical Science in 1986 and his Doctor of Medicine in 1989 at the University of the Philippines in Manila, Philippines. He completed a residency in internal medicine in 1994, becoming Chief Resident in 1993 at the State University of New York at Stony Brook. He then began a fellowship in the Division of Cardiology at Montefiore in 1994. In 1999, Dr. Palma completed a fellowship in Cardiac Electrophysiology at the University of California at San Francisco at the Cardiovascular Research Institute.</p><p>Dr. Palma’s research has focused on the outcomes of catheter ablation and pioneering interventional electrophysiology techniques, including subclavian and coronary sinus venoplasty for cardiac resynchronization therapy. His research has been published in various articles, including “Subclavian Venoplasty May Reduce Implant Times and Implant Failures in the Era of Increasing Device Upgrades” in Pacing and Clinical Electrophysiology and “Coronary Sinus Venoplasty for Optimal Left Ventricular Lead Placement in Cardiac Resynchronization Therapy” in the Journal of Innovations in Cardiac Rhythm Management, as well as numerous peer-reviewed journals and books.</p><p>In 1994, Dr. Palma received the Northport VAMC First Annual Chiefs’ Award for outstanding achievements in laboratory medicine. He is board certified by the American Board of Internal for Clinical Cardiac Electrophysiology,a Fellow of the American College of Cardiology, and a member of the Heart Rhythm Society.</p>
<p>Dr. Robert Ostfeld is the founder and director of the Cardiac Wellness Program at Montefiore, an Associate Professor of Clinical Medicine and Albert Einstein College of Medicine, and the Associate Director of the Cardiology Fellowship at Einstein-Montefiore.</p>
<p>Dr. Ostfeld is the author of over 2 original articles and has authored numerous book chapters, reviews, and clinical statements. His professional interests include cardiovascular disease prevention, medical education, and clinical research. He speaks frequently to both the medical and lay community regarding cardiovascular disease prevention.</p>
<p>Dr. Ostfeld earned the outstanding Full-Time Attending of the Year award at Montefiore for excellence in teaching medical residents, received the Program Director's Award for dedicated service on behalf of the Montefiore Einstein Cardiology Fellowship, and was elected to the Leo M. Davidoff Society at Einstein for outstanding achievement in the teaching of medical residents.</p>
<p><strong>Education</strong></p>
<p>Undergraduate: University of Pennsylvania, 1992. Summa Cum Laude and Phi Beta Kappa </p>
<p>Medical School: Yale University School of Medicine, 1996. </p>
<p>Medical Internship: Massachusetts General Hospital, Harvard Medical School, 1996-1997. </p>
<p>Medical Residency: Massachusetts General Hospital, Harvard Medical School, 1997-1999. </p>
<p>Cardiology Fellowship: Brigham and Women's Hospital, Harvard Medical School, 1999-2003. </p>
<p>Research Fellowship in Preventive Medicine: Brigham and Women's Hospital, Harvard Medical School, 2002-2003. </p>
<p>Master's of Science in Epidemiology: Harvard School of Public Health, 2003. </p>
<p><strong>Clinical Research Interests</strong></p>
<p>Preventive Cardiology, General Cardiology, Valvular Heart Disease, Echocardiography, Medical Education</p>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure.</span>
<p>Robert J. Ostfeld, MD, MSc, FACC, is the Director of Preventive Cardiology at Montefiore Health System and a Professor of Medicine at the Albert Einstein College of Medicine. Dr. Ostfeld treats patients with adult cardiovascular disease, including coronary artery disease, hypertension, hyperlipidemia, and erectile dysfunction with a focus on prevention and treatment through lifestyle change. He works closely with his patients to help them adopt a plant-based diet.</p><p>Dr. Ostfeld received his Bachelor of Arts in the Biologic Basis of Behavior from the University of Pennsylvania, graduating Summa Cum Laude and Phi Beta Kappa and his Doctor of Medicine from Yale University School of Medicine. He then did his Medical Internship and Residency at the Massachusetts General Hospital and his Cardiology Fellowship and Research Fellowship in Preventive Medicince at Brigham and Women’s Hospital, both teaching hospitals of Harvard Medical School. During his Cardiology Fellowship, he earned a Master’s of Science in Epidemiology from the Harvard School of Public Health.</p><p>Dr. Ostfeld’s research focus is on cardiovascular disease prevention and reversal through lifestyle modification. Ongoing topics he investigates include the impact of plant-based nutrition on erectile function, coronary artery disease, angina, and heart failure. His work has been published in peer-reviewed journals, books, articles, and clinical statements and has been presented nationally.</p><p>Dr. Ostfeld is board certified in Cardiovascular Disease and Echocardiography and he is a member of numerous professional societies, including the Physician’s Committee for Responsible Medicine and the American College of Cardiology. </p>
<p>During his 31-year career at Einstein, Dr. Charles W. Nordin, currently Professor of Medicine, has been a distinguished clinician and gifted educator. An attending cardiologist at Montefiore and Jacobi Medical Centers since 1983, Dr. Nordin also served as Chair of Medicine at Jacobi/North Central Bronx Hospital and co-director of the Einstein-sponsored medicine residency program at Jacobi from 1997 to 2009.</p>
<p>As an educator, Dr. Nordin has been co-director (with Dr. Steven Factor) of Einstein’s second-year Cardiovascular System course for the past 21 years. In 2010, he was asked to assume directorship of the first-year Cardiovascular Physiology course as well, vastly improving student understanding of and competence in this challenging subject. Dr. Nordin’s excellence in teaching has been recognized numerous times, first by his election to the Leo M. Davidoff Society. He subsequently received the student-nominated Samuel M. Rosen Award for Outstanding Teaching (Basic Science) in 1996 and the Harry Eagle Award for Outstanding Basic Science Teaching in 1999. The following year, he was chosen by the graduating M.D. class as its Alpha Omega Alpha Faculty Inductee.</p>
<p>Dr. Nordin is a member of the scientific council of the American Heart Association and serves as a journal reviewer for numerous publications, including Cardiovascular Research, the Journal of Molecular and Cellular Cardiology and the American Journal of Physiology. A native of Iowa, Dr. Nordin comes from a family of physicians, including his father, grandfather and two brothers. He received his bachelor’s degree summa cum laude from Yale in 1971 and his medical degree from Harvard in 1976. Following his internship and residency at Bellevue Hospital, he spent a year as a research fellow in cardiology at Einstein before joining the Einstein faculty in 1983.</p>
<ul>
<li>Member of the Einstein Faculty since 1983; Currently Professor of Medicine at Einstein</li>
<li>Basic research in cardiac electrophysiology, 1983 to 1997</li>
<li>Chairman of Medicine, Jacobi Medical Center (one of New York City's municipal hospitals and a primary Einstein affiliate) 1997-2009. Currently Attending Cardiologist, Montefiore Medical Center </li>
<li>Clinical research in diabetes screening, nonpharmacologic causes of QT prolongation, cocaine and beta blockers, proarrhythmic effects of hypoglycemia 2004-present</li>
<li>Director of the 1st and 2nd year ourse in Cardiovascular Medicine, Albert Einstein College of Medicine</li>
<li>Practicing cardiologist in the Bronx: Attending, Coronary Care Unit and Medicine Wards at Jacobi, 1983 to present. Attending, Montefiore Medical Center, 1983-present. Specific interest in practice of cardiology in community clinic setting in the Bronx</li>
</ul>
<div>
<p style="text-align: justify;"> </p>
<p style="text-indent: .25in; text-align: justify;"><strong>A. Original Communications in Reviewed Journals</strong></p>
<p style="text-align: justify;">l. Fein, F., Aronson, R.S., <strong>Nordin, C.</strong>, Miller‑Green, B., and Sonnenblick, E.H.: Altered myocardial response to ouabain in diabetic rats: Mechanics and electrophysiology. Journal of Molecular and Cellular Cardiology l5: 769‑784, l983.</p>
<p style="text-align: justify;">2. Aronson, R., and <strong>Nordin, C.</strong>: Electrophysiologic properties of hypertrophied myocytes isolated from rats with renal hypertension. European Heart Journal 5 (Suppl. F): 339‑345, l984.</p>
<p style="text-align: justify;">3. Fein, F., Capasso, J., Aronson, R., Cho, S., <strong>Nordin, C.</strong>, Miller‑Green, B., Sonnenblick, E. and Factor, S.: Combined renovascular hypertension and diabetes in rats: A new model of congestive cardiomyopathy. Circulation 70: 3l8‑330, l984. </p>
<p style="text-align: justify;">4. <strong>Nordin, C.</strong>, Gilat, E. and Aronson, R.S.: Delayed afterdepolarizations and triggered activity in ventricular muscle in rats with streptozotocin induced diabetes. Circulation Research 57: 28‑34, l985.</p>
<p style="text-align: justify;">5. Aronson, R.S. and <strong>Nordin, C.</strong>: Arrhythmogenic interaction between low potassium and ouabain in isolated guinea‑pig ventricular myocytes. Journal of Physiology 400: 113‑134, 1988.</p>
<p style="text-align: justify;">6. <strong>Nordin, C.</strong>, Siri, F., Aronson, R: Electrophysiologic characteristics of single myocytes isolated from hypertrophied guinea pig hearts. Journal of Molecular and Cellular Cardiology 21: 729‑739, 1989.</p>
<p style="text-align: justify;">7. Arbeeny, C.M., <strong>Nordin, C.</strong>, Edelstein, D., Stram, N., and Eder, H.: Hyperlipoproteinemia in spontaneously diabetic guinea pigs. Metabolism 38: 895‑900, 1989.</p>
<p style="text-align: justify;">8. Siri, F., <strong>Nordin, C.</strong>, Factor, S., Sonnenblick E., and Aronson, R.: Compensatory hypertrophy and failure in gradual pressure overloaded guinea pig heart. American Journal of Physiology 257 (Heart Circ. Physiol. 26): H1016‑H1024, 1989.</p>
<p style="text-align: justify;">9. Gilat, E., <strong>Nordin, C.</strong>, and Aronson, R.: The role of reduced potassium conductance in generating triggered activity in ventricular muscle. Journal of Molecular and Cellular Cardiology 22: 619‑628, 1990.</p>
<p style="text-align: justify;">10. Gilat, E., Aronson, R., and <strong>Nordin, C.</strong>: Triggered activity induced by K<sup>+</sup>‑ free, Na<sup>+</sup> deficient solution in guinea pig ventricular muscle: The effects of ouabain, lidocaine, and Ca<sup>2+</sup> channel blockers. Journal of Cardiovascular Pharmacology 16: 267‑275, 1990.</p>
<p style="text-align: justify;">11. Siri, F., Krueger, J., <strong>Nordin, C.</strong>, Ming, Z., and Aronson, R.: Depressed intracellular calcium transients and contraction in myocytes from hypertrophied and failing guinea pig hearts. American Journal of Physiology 261: (Heart Circ. Physiol. 30): H514‑H530, 1991.</p>
<p style="text-align: justify;">12. <strong>Nordin, C.</strong>: Computer model of membrane current and intracellular Ca<sup>2+</sup> flux in the isolated guinea pig ventricular myocyte. American Journal of Physiology 265 (Heart Circ. Physiol 34): H2117‑H2136, 1993 </p>
<p style="text-align: justify;">13. Ming, Z., <strong>Nordin, C.</strong>, and Aronson, R.S.: Role of L-type calcium channel window current in generating current‑induced early afterdepolarizations. Journal of Cardiovascular Electrophysiology 5:323‑334, 1994</p>
<p style="text-align: justify;">14. Ming, Z., <strong>Nordin, C.</strong>, Siri, F.M., and Aronson, R.S.: Reduced calcium current density in single myocytes isolated from hypertrophied failing guinea pig hearts. Journal of Molecular and Cellular Cardiology, 26: 1133-1143, 1994.</p>
</div>
<p style="text-align: justify;">15. Ming, Z., Aronson, R.S. and <strong>Nordin, C</strong>: Mechanism of current-induced early afterdepolarizations in isolated guinea pig myocytes. American Journal of Physiology, 267 (Heart Circ. Physiol 36): H1419-1428, 1994.</p>
<p style="text-align: justify;">16. <strong>Nordin, C.</strong> and Ming, Z.: Computer model of current-induced early afterdepolarizations in guinea pig myocytes. American Journal of Physiology 268 (Heart Circ. Physiol. 37): H2440-H2459, 1995.</p>
<p style="text-align: justify;">17. Ming, Z. and <strong>Nordin, C.</strong> Terfenadine blocks time-dependent Ca<sup>2+</sup>, Na<sup>+</sup> and K<sup>+</sup> channels in guinea pig ventricular myocytes. Journal of Cardiovascular Pharmacology 26: 761-769, 1995</p>
<p style="text-align: justify;">18. <strong>Nordin, C.</strong> Effect of Ca<sup>2+</sup> loading on response of depolarized guinea pig myocytes to premature stimulations. American Journal of Physiology 270 (Heart Circ. Physiol. 39): H447-H465, 1996.</p>
<p style="text-align: justify;">19. <strong>Nordin, C.</strong>: Computer model of electrophysiologic instability in very small heterogeneous ventricular syncytia. American Journal of Physiology 272 (Heart Circ. Physiol. 34): H1838-H1856, 1997.</p>
<p style="text-align: justify;">20. Grant, T, Soriano, Y, Marantz P, Nelson, I, Williams, E, Ramirex, D, Burg, J, and <strong>Nordin, C.</strong> Community-based screening for cardiovascular disease and diabetes using HbA1c. American Journal of Preventive Medicine 26: 271-275, 2004. </p>
<p style="text-align: justify;">21. <strong>Nordin, C</strong>, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz P. Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: Prevalence and effect on mortality. Cardiology in Review 13: 223-230, 2005.</p>
<p style="text-align: justify;">22<strong>. Nordin,C,</strong> Kohli A, Beca S, Zaharia V, Grant T, Leider J, Marantz P. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. Journal of Electrocardiology, 39: 19-205, 2006.</p>
<p style="text-align: justify;">23. Dattilo, PB, <strong>Nordin, C</strong>. Case report: Prolonged QT associated with an overdose of trazodone. Journal of Clinical Psychiatry, in press.</p>
<p> 24. Dattilo PB, Hailper ,S, Fearon K, Sohal D<strong>, Nordin C</strong>.Beta Blockers Are Associated with Reduced Risk of Myocardial Infarction following Cocaine Use. Annals of Emergency Medicine 51: 117-125, 2008.</p>
<p> 25. Mazurek JA, Hailpern SM, GoringT, <strong>Nordin C</strong>. Prevalence of Hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. Journal of Clinical Endocrinology and Metabolism, 2010, epub</p>
<p> </p>
<p style="margin-bottom: .0001pt; margin-top: 0in; margin-right: 0in; font-family: 'CG Times'; margin-left: 0in; text-autospace: none; font-size: 10.0pt;"> </p>
<p style="margin-bottom: .0001pt; margin-top: 0in; margin-right: 0in; font-family: 'CG Times'; margin-left: 0in; text-autospace: none; font-size: 10.0pt;"> </p>
<p style="text-align: justify; text-indent: .25in;"><strong>B. Books, Chapters in Books, and Review Articles:</strong></p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;">1. <strong>Nordin, C.</strong>: Basic relationships between congestive heart failure and ventricular arrhythmias. Heart Failure l: 256‑270, l986.</p>
<p style="text-align: justify;">2. <strong>Nordin, C.</strong> and Aronson, R.S.: Interactions between oscillatory currents and membrane conductance in isolated cardiac ventricular myocytes: Experimental description and preliminary modeling. In <em>Activation, Metabolism and Perfusion of the Heart</em> S. Sideman, R. Beyar Eds., Martinus Nihoff, 1987, pp. 151‑171.</p>
<p style="text-align: justify;">3. <strong>Nordin, C.</strong>: Abnormal Ca<sup>2+</sup> handling and the generation of ventricular arrhythmias in congestive heart failure. Heart Failure 5:147‑154, 1989.</p>
<p style="text-align: justify;">4. <strong>Nordin, C.</strong>: Computer modeling of interactions between normal and damaged myocytes: New approaches to the etiology of ventricular arrhythmias. In <em>Modeling and Control in Biomedical Systems: Proceedings of the IFAC Symposium.</em> B.W. Patterson, ed. Madison: Omnipress, 1994, pp.70‑75.</p>
<p style="text-align: justify;"> </p>
<p style="text-align: justify;"> </p>
<p>Dr. Shadi Nahvi is Professor (with tenure) in the Departments of Medicine and Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine, and directs the General Internal Medicine and Addiction Medicine Fellowship Programs. Her research focuses on optimizing quality of life and health outcomes among persons with substance use disorder.</p>
<p>Dr. Nahvi’s research is grounded in nearly two decades of clinical experience as a primary care physician caring for persons with opioid and other substance use disorders. Her primary research focus is optimizing the efficacy and delivery of tobacco cessation treatments among persons with co-occurring substance use disorders. Currently, she is Principal Investigator of a NIDA R01-funded randomized, 2 x 2 factorial trial of directly observed and long-term varenicline treatment among smokers with opioid use disorder. She has also led a KL2 Career Development Award-funded, randomized, placebo-controlled pilot trial of varenicline for smoking cessation among smokers with co-morbid substance use disorder, a study of health system-level interventions to increase documentation and treatment of tobacco use among substance use disorder counselors, and a randomized trial of the efficacy of directly observed varenicline provided at a methadone clinic for promoting smoking cessation and enhancing adherence. </p>
<p>Dr. Nahvi graduated from the Brown University School of Medicine in 2001 and completed residency training in Primary Care Internal Medicine at Bellevue Hospital and New York University Medical Center in 2004. She then joined the faculty in the Albert Einstein College of Medicine Division of Substance Abuse as the Medical Director of an opioid treatment program.</p>
<p>Dr. Nahvi has served on numerous national advisory committees, including serving as a member of the NY State Department of Health AIDS Institute’s Guideline Committee for the Care of Substance Users and a Steering Committee member of the NY State Department of Health AIDS Institute's Tobacco Cessation Improvement Campaign.</p>
<p>Selected recent publications:</p>
<p>Nahvi S, Segal KS, Litwin AH, Arnsten JH. Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. <em>Addiction Science and Clinical Practice. </em>2014, 13;9:9</p>
<p class="Normal">Nahvi S, Blackstock O, Sohler NL, Thompson D, Cunningham CO. Smoking cessation treatment among office-based buprenorphine treatment patients. <em>Journal of Substance Abuse Treatment. </em>2014, 47(2):175-9</p>
<p>Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH. Varenicline efficacy and safety among methadone maintained smokers: A randomized placebo-controlled trial. <em>Addiction. </em>2014, 109(9):1554-63</p>
<p>Griffin J, Segal KS, Arnsten JH, Nahvi S. Barriers to telephone quitline use among methadone maintained smokers. <em>Nicotine & Tobacco Research.</em> 2015,17(8):931-6</p>
<p>Batchelder AW, Peyser D, Nahvi S, Arnsten JH, Litwin AH. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to Hepatitis C treatment. <em>Drug and Alcohol Dependence.</em> 2015, 153:66-71</p>
<p>Maradiaga J, Nahvi S, Cunningham CO, Sanchez J, Fox AD. "I kicked the hard way. I got incarcerated." Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. <em>Journal of Substance Abuse Treatment.</em> 2016, 62:49-54</p>
<p>Fitzgerald SA, Faseru B, Mussulman L, Howser E, Nahvi S, Goggin K, Cooperman NA, Richter KP. Improving quality of care for hospitalized smokers with HIV: Tobacco dependence treatment referral and utilization. <em>The Joint Commission Journal on Quality and Patient Safety.</em> 2016, 42(5):219-24</p>
<p>Shah PA, Cunningham CO, Blackstock OJ, Brisbane MT, Nahvi S. Use of smoking cessation methods among patients receiving office-based buprenorphine maintenance treatment. <em>Journal of Addiction Medicine.</em> 2017, 11(6):494-497</p>
<p>Adams TR, Arnsten JH, Ning Y, Nahvi S. Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use. <em>Journal of Psychoactive Drugs.</em> 2018, 50(1):12-18</p>
<p>Sohler NL, Starrels J, Khalid L, Bachhuber M, Arnsten JH, Nahvi S, Jost J, Cunningham CO. Marijuana use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. <em>Substance Use and Misuse. </em>2018, 17:1-6</p>
<p>Minami H, Brinkman HR, Nahvi S, Arnsten JH, Rivera-Mindt M, Wetter DW, Litvin Bloom E, Price LH, Vieira C, Donnelly R, McClain LM, Kennedy KA, D'Aquila E, Fine M, McCarthy DE, Thomas JG, Hecht J, Brown RA. Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND. <em>Contemporary Clinical Trials. </em>2018, 66:26-44</p>
<p>Weinberger AH, Pacek LR, Wall MM, Zvolensky MJ, Copeland J, Galea S, Nahvi S, Moeller SJ, Hasin DS, Goodwin RD. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002 to 2016. <em>Drug and Alcohol Dependence.</em> 2018, 191:45-51</p>
<p>Nahvi S, Arnsten JH. Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders. <em>Drug and Alcohol Dependence. </em>2018, 185: 245-247.</p>